Friday, December 19, 2008

Liver function needs to be monitored in lung cancer patients taking Tarceva

TORONTO - The drug company Hoffman-La Roche is informing doctors about new safety information for one of its drugs used by lung cancer patients. It says liver function needs to be closely monitored by the doctor in patients who currently or recently have taken Tarceva....More

No comments: